Buscar | Kontentz

Chirag Roy agregó una foto Other
2026-04-23 07:27:30 -

Clonality-Based Testing Using ABI Fluorescence Detection: Advancing Precision in Hematologic Diagnostics
In modern oncology and molecular diagnostics, the ability to accurately identify and characterize clonal cell populations has become essential. Clonality-based testing, particularly using ABI fluorescence detection, plays a critical role in diagnosing and monitoring hematological malignancies such as leukemia and lymphoma. With advancements in PCR-based technologies and capillary...

0 Commentarios 0 Acciones 16K Views 0 Vista previa

Please log in to like, share and comment!
Prasad Shinde agregó una foto Other
2026-09-08 09:45:19 -

Companion Diagnostics Market Enters a New Era of Biomarker-Led Treatment
The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Prasad Shinde agregó una foto Other
2026-09-16 05:33:19 -

Immunoassay Market Growth Finds Fresh Opportunities in Decentralized Testing
The immunoassay market is entering a period of steady expansion as healthcare systems increasingly prioritize early disease detection, biomarker analysis, personalized medicine, and rapid diagnostic testing. The market was valued at USD 28.0 billion in 2025 and is estimated to reach USD 29.3 billion in 2026, before growing to USD 40.3 billion by 2033. It is projected to expand at a 4.6% CAGR...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Prasad Shinde agregó una foto Other
2026-09-22 10:21:00 -

Why Faster Testing Is Reshaping Autoimmune Disease Diagnostics Market Growth
The autoimmune disease diagnostics market is gaining momentum as the growing burden of autoimmune disorders increases demand for early, accurate, and efficient disease detection. The market was valued at USD 6.1 billion in 2025 and is estimated to reach USD 6.4 billion in 2026. It is projected to expand to USD 9.6 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033. The increasing...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Prasad Shinde agregó una foto Other
2026-08-13 11:50:13 -

Why Mass Spectrometry Remains a Core Technology in Proteomics Research
The proteomics market is entering a period of rapid expansion as healthcare and life sciences organizations increasingly use protein analysis to understand disease mechanisms, identify biomarkers, develop targeted therapies, and advance personalized medicine. The market was valued at USD 38.4 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 97.7 billion by 2033,...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!